NMC

NEA Management Company Portfolio holdings

AUM $1.33B
This Quarter Return
+6.39%
1 Year Return
+85.82%
3 Year Return
+531.37%
5 Year Return
+304.32%
10 Year Return
+4,927.96%
AUM
$2.04B
AUM Growth
+$2.04B
Cap. Flow
+$63.5M
Cap. Flow %
3.12%
Top 10 Hldgs %
82.41%
Holding
32
New
3
Increased
–
Reduced
4
Closed
4

Top Buys

1
CBIO
Crescent Biopharma, Inc. Common Stock
CBIO
$140M
2
RNA
PROSENSA HLDGS N V ORD SHS (NLD)
RNA
$36.5M
3
TRVN
Trevena, Inc.
TRVN
$30M

Top Sells

1
CVT
CVENT, INC.
CVT
$47.1M
2
ECOM
CHANNELADVISOR CORPORATION
ECOM
$41.7M
3
GLUU
Glu Mobile Inc.
GLUU
$23.1M
4
CADX
CADENCE PHARMACEUTICALS, INC COM STK
CADX
$18.7M
5
SLTM
SOLTA MED INC (DE)
SLTM
$8.44M

Sector Composition

1 Healthcare 50.85%
2 Communication Services 23.71%
3 Technology 16.3%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
GRPN icon
1
Groupon
GRPN
$1.06B
$426M 20.92% 54,351,582 – –
TSRO
2
DELISTED
TESARO, Inc.
TSRO
$291M 14.26% 9,854,255 -7,157 -0.1% -$211K
CVT
3
DELISTED
CVENT, INC.
CVT
$217M 10.64% 5,996,212 -1,302,934 -18% -$47.1M
CLVS
4
DELISTED
Clovis Oncology, Inc.
CLVS
$158M 7.75% 2,279,781 – –
EPZM
5
DELISTED
Epizyme, Inc
EPZM
$147M 7.21% 6,446,089 – –
CBIO
6
Crescent Biopharma, Inc. Common Stock
CBIO
$200M
$140M 6.87% +8,575,135 New +$140M
SUPN icon
7
Supernus Pharmaceuticals
SUPN
$2.53B
$95.2M 4.67% 10,650,000 – –
HPTX
8
DELISTED
HYPERION THERAPEUTICS INC COM STK (DE)
HPTX
$74.4M 3.65% 2,884,221 – –
FIO
9
DELISTED
FUSION-IO INC COM
FIO
$74M 3.64% 7,038,379 – –
MM
10
DELISTED
MILLENNIAL MEDIA INC COM STK (DE)
MM
$56.9M 2.79% 8,224,752 – –
ITMN
11
DELISTED
INTERMUNE INC
ITMN
$44.9M 2.2% 1,341,000 – –
VIRX
12
DELISTED
Viracta Therapeutics, Inc. Common Stock
VIRX
$37.3M 1.83% 5,636,573 – –
RNA
13
DELISTED
PROSENSA HLDGS N V ORD SHS (NLD)
RNA
$36.5M 1.79% +6,480,171 New +$36.5M
WIFI
14
DELISTED
Boingo Wireless, Inc.
WIFI
$30.3M 1.49% 4,467,960 – –
TRVN
15
DELISTED
Trevena, Inc.
TRVN
$30M 1.47% +3,811,691 New +$30M
NKTR icon
16
Nektar Therapeutics
NKTR
$568M
$22.1M 1.09% 1,825,600 – –
GYRE icon
17
Gyre Therapeutics
GYRE
$703M
$21.7M 1.06% 4,566,666 – –
ECOM
18
DELISTED
CHANNELADVISOR CORPORATION
ECOM
$21M 1.03% 556,692 -1,104,665 -66% -$41.7M
LXRX icon
19
Lexicon Pharmaceuticals
LXRX
$400M
$20.2M 0.99% 11,676,000 – –
DZSI
20
DELISTED
DZS Inc. Common Stock
DZSI
$20.2M 0.99% 4,781,290 – –
ALIM
21
DELISTED
Alimera Sciences, Inc.
ALIM
$17.8M 0.87% 2,255,639 -425,611 -16% -$3.36M
RIGL icon
22
Rigel Pharmaceuticals
RIGL
$697M
$12.6M 0.62% 3,243,150 – –
OREX
23
DELISTED
Orexigen Therapeutics, Inc.
OREX
$12.6M 0.62% 1,935,300 – –
FOLD icon
24
Amicus Therapeutics
FOLD
$2.34B
$11.7M 0.57% 5,653,029 – –
EXEL icon
25
Exelixis
EXEL
$10.1B
$7.81M 0.38% 2,207,000 – –
1
2